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Abstract 
Background: Mitochondrial dysregulation is important in axonal damage and demyelination in multiple sclerosis 
(MS) and experimental autoimmune encephalomyelitis (EAE). There is however, no evidence in the literature of any 
study that has examined cellular bioenergetics of the central nervous system (CNS) during the early development and 
clinical course of EAE. EAE, a rodent model of relapsing/remitting MS, is a CD4+ T cell‑mediated disease of the CNS. 
We hypothesize that CNS bioenergetics might predict prognosis, and that preserved bioenergetics might underlie 
the remission from disease. The study aims therefore, to determine whether the clinical history of EAE is influenced by 
cellular respiration of the CNS in susceptible Dark Agouti (DA) and resistant Albino Oxford (AO) rats.
Methods: Experimental autoimmune encephalomyelitis was induced by myelin basic protein in complete Freud 
Adjuvant in the footpads of DA and AO rats. A phosphorescence analyzer that determines cellular respiration was 
used to monitor oxygen consumption and ATP concentration was measured using the Enliten ATP assay system. Dis‑
ease pathology was demonstrated by H&E and Luxol fast blue staining of sections of the lumbar regions of the spinal 
cord. Mitochondrial size in relation to axonal size was determined by electron microscopy. Apoptosis was studied by 
HPLC measurement of intracellular caspase‑3 activity and caspase immunohistochemistry. Role and source of caspase 
1 was studied by double immunofluorescence with antibodies for caspase‑1, microglia (anti‑Iba1) and astrocytes 
(anti‑GFAP).
Results: The cellular respiration of the CNS did not vary between diseased and normal rats. We also demonstrate 
here, that at the peak of disease, inflammation as shown by caspase‑1, produced by activated microglia and infiltrat‑
ing cells, was significant in susceptible DA rats. The mitochondrial:axonal size ratio did not vary in the different groups 
although mitochondria were smaller in spinal cords of diseased DA rats. Demyelination, observed only in areas of 
mononuclear infiltration of the spinal cord of diseased DA rats, was demonstrated by light microscopy and electron 
microscopy.
Conclusion: We conclude that EAE at this early stage does not significantly affect CNS cellular respiration and this 
might underlie the reason for the recovery of diseased rats.
© 2015 Al‑Shamsi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Cellular bioenergetics which is the biochemical processes 
involved in energy metabolism (energy conversion or 
transformation) and cellular respiration (mitochondrial 
O2 consumption), describes the delivery of metabo-
lites and O2 to mitochondria, the oxidation of reduced 
metabolic fuels with passage of electrons to O2, and the 
synthesis of ATP. Impaired cellular bioenergetics or res-
piration, thus, entails an interference with any of these 
processes. Work by Mahad et  al. [1] and several others 
have demonstrated the importance of mitochondrial 
dysregulation and mitochondria-derived reactive oxy-
gen species (ROS) to axonal damage and demyelination 
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in multiple sclerosis (MS) and experimental autoimmune 
encephalomyelitis (EAE) [1–8]. While the EAE model has 
been successfully employed to investigate the mechanism 
of MS, there is no evidence in the literature of any study 
that has examined cellular bioenergetics of the central 
nervous system (CNS) during the early development and 
clinical course of EAE. This study would attempt to pro-
vide an explanation for some of the features of EAE, most 
significant of which is that, diseased rodents apparently 
recover with minimal neurological deficits. Recovery has 
been attributed to the downregulation of proinflamma-
tory cytokines resulting from the clearance of infiltrating 
T cells by activated microglia [9].
Experimental autoimmune encephalomyelitis is a 
rodent model for relapsing/remitting type of MS [10, 11]. 
Injection of encephalitogenic emulsion into the footpads 
of rats induces disease in the genetically susceptible Dark 
Agouti (DA), but not the resistant Albino Oxford (AO) 
strains although mild inflammation occurs in both strains 
early after disease induction [12–14]. The active phase of 
the MS lesion and EAE is also characterized by the infil-
tration of T lymphocytes and monocyte-derived mac-
rophages, which initiate demyelination [15, 16]. These 
cells together with activated microglia have been shown 
to by several other workers [1, 2, 17, 18] to secreted pro-
inflammatory mediators and oxidizing radicals, such as 
superoxide anion, hydroxyl radicals, hydrogen peroxide, 
and nitric oxide (NO), which are believed to be responsi-
ble for the demyelination and axonal damage in MS and 
EAE.
Apoptosis describes highly regulated mechanisms 
responsible for cellular responses to injuries or biologic 
signals. Caspases-1 and -3, cysteine aspartate-directed 
proteases and members of the interleukin-1β-converting 
enzyme (ICE) group, are the key executors of apoptosis 
and inflammation [19, 20]. Activation of caspases leads to 
the opening of the transitional permeability pores in the 
inner mitochondrial membranes, which results in uncou-
pling oxidative phosphorylation as well as rapid cellular 
ATP and nutrient depletion. This process produces del-
eterious morphological and biochemical changes, includ-
ing mitochondrial disturbances which may cause cell 
death. MS and EAE result from apoptosis of oligodendro-
cytes arising from the effect of inflammation induced by 
infiltrating mononuclear and resident CNS cells [21–24]. 
We have in this study investigated spinal tissue respira-
tion (cellular mitochondrial O2 consumption) in MBP-
induced EAE in rats using a sensitive in vitro system that 
employs a phosphorescence analyzer to measure O2 con-
centration as a function of time in tissues. We have also 
measured the sizes of mitochondria and the axons within 
which they occur, to determine the presence of any mor-
phological evidence of impairment of mitochondrial 
function. We show here that spinal tissue respiration 
appears preserved and the differences in the ratio of 
mitochondrial:axonal sizes are insignificant between the 
groups studied. Further, we have shown increased levels 
of apoptosis in diseased DA rats by caspase-3 immuno-
histochemistry and by measuring the ability of caspase-3 
to cleave Ac-DEVD-AMC to release the fluorogenic moi-
ety, 7-amino-4-methylcoumarin (AMC). By means of 
double immunofluorescence using rabbit anti-caspase 1 
either with goat anti- Ionized calcium binding adaptor 
molecule 1 (Iba-1) for microglia [25] and with mouse anti 
glial fibrillary acidic protein (GFAP) [26] for astrocytes, 
we have shown that caspase 1 induced inflammation [27] 
is important in disease development in EAE and micro-
glia together with other infiltrating mononuclear cells are 
the source of caspase-1. Activated microglial cells have 
been shown to mediate axoglial disruption that contrib-
utes to axonal damage in multiple sclerosis [28].
Our hypothesis is that CNS bioenergetics might pre-
dict prognosis, and that preserved bioenergetics, as 
observed in this initial wave of EAE, might underlie the 
remission from disease. Any intervention, therefore, that 
sustains cellular energy metabolism during the course of 
EAE would be expected to improve disease outcome.
Methods
Animals
Male Dark Agouti (DA) and Albino Oxford (AO) rats 
(8–12-week-old) weighing between 250 and 300  g used 
in this study were maintained at the animal facility of the 
College of Medicine and Health Sciences, UAE Univer-
sity in compliance with NIH guidelines (http://grants.
nih.gov/grants/olaw/references/phspol.htm). Although 
female rats are generally more susceptible to autoimmun-
ity, male rats were used in this study because previous 
studies by Lenz et  al. [29] and others [13, 14, 30] since 
then, have revealed no gender differences in disease sus-
ceptibility. All rats were housed in rooms maintained at 
22°C with ~60% relative humidity and a 12-h light/dark 
cycle. All rats had ad libitum access to standard rodent 
chow and filtered water. All protocols used here received 
approval from the Animal Research Ethics Committee, 
United Arab Emirates University.
For these studies, experimental rats were anaesthetized 
by intra-peritoneal injection of 1.5 ml/100 g (BW) of ure-
thane [using 20% solution (w/v) in 0.9% NaCl].
Reagents
The Pd(II) complex of meso-tetra-(4-sulfonatophenyl)-
tetrabenzoporphyrin (Pd phosphor) was obtained from 
Porphyrin Products (Logan, UT, USA). Dactinomy-
cin (actinomycin D, MW ≈  1,255) was purchased from 
Merck (Whitehouse Station, NJ, USA). A lyophilized 
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powder of caspase inhibitor I (zVAD-fmk, MW ≈ 467.5) 
was purchased from Calbiochem (La Jolla, CA, USA). 
Ac-DEVD-AMC (MW ≈ 729.6) and caspase-3 (molecu-
lar mass ≈ 30.5 kDa, heterodimer active human recombi-
nant) were purchased from Axxora LLC (San Diego, CA, 
USA). Glucose [anhydrous], bovine serum albumin (free 
of endotoxin and fatty acids), and remaining reagents 
were bought from Sigma-Aldrich (St. Louis, MO, USA).
Dactinomycin solution was made fresh in dH2O; its 
concentration was determined by absorbance at 440 nm, 
using an extinction coefficient of 24,450 M−1 cm−1 [31]. 
The zVAD-fmk solution (2.14 mM) was made by dissolv-
ing 1.0 mg of zVAD-fmk in 1.0 ml of dimethyl sulfoxide 
and stored at −20°C. The Ac-DEVD-AMC caspase sub-
strate was dissolved in dimethyl sulfoxide at a concentra-
tion of 6.85  mM and stored at −20°C in small aliquots. 
Phosphate-buffered saline (PBS) with glucose (137  mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, 
and 5 mM glucose; pH 7.4) was made fresh. NaCN solu-
tion (1.0 M) was prepared in dH2O; the pH was adjusted 
to ~7.0 with 12 N HCl and stored at −20°C.
Induction of EAE
Groups of DA and AO rats (n =  5) were immunized in 
the left hind foot pad with 0.1 ml antigenic emulsion con-
taining rat spinal cord tissue and 100  μg of rat myelin 
basic protein (MBP) with complete Freund’s adjuvant 
(CFA) (both obtained from Sigma-Aldrich, St Louis, 
MO, USA). Animals were monitored for clinical disease 
starting from day 4 after immunization. The severity of 
disease was assessed by grading tail, hind limb and fore-
limb weakness, each on a scale of 0–4 [12, 13]. Briefly, 
zero indicated no disease, 1—loss of tail tonicity, 2—hind 
limb weakness, 3—hind limb paralysis, and 4—moribund 
or death. Spinal cord specimens of the lumbar region of 
immunized DA and AO rats were excised at induction, 
peak of disease and resolution phases of the disease. Spi-
nal cord specimens were also collected from non-immu-
nized DA rats. For analysis, DA rats at peak of disease 
(grade 3+) which occurred on days after immunization 
which varies (9–14 days) were used.
Excision of spinal cord tissue
Spinal cord specimen (18–30 mg/rat) were excised from 
the lumbar region using a sharp scalpel blade. Follow-
ing protocols previously outlined [32, 33], the specimens 
were immediately immersed in ice-cold oxygenated 
Krebs–Henseleit buffer [115 mM NaCl, 25 mM NaHCO3, 
1.23  mM NaH2PO4, 1.2  mM Na2SO4, 5.9  mM KCl, 
1.25 mM CaCl2, 1.18 mM MgCl2, and 6 mM glucose (pH 
7.2)], weighed and then placed in 1.0 ml Krebs buffer con-
taining 0.5% fat-free bovine albumin and 3 μM Pd phos-
phor for O2 measurements. Unless otherwise noted, the 
time period between specimen collection and start of O2 
measurement was <5 min. Where stated, specimens were 
incubated in vitro at 37°C in Krebs–Henseleit solution 
gassed with 95% O2:5% CO2 prior to O2 measurements.
Oxygen measurements
A phosphorescence oxygen analyzer was used to moni-
tor O2 consumption by spinal cord specimens [32, 33]. 
O2 detection was performed with the aid of Pd phosphor 
that had an absorption maximum at 625 nm and a phos-
phorescence maximum at 800 nm. Samples were exposed 
to light flashes (600 per min) from a pulsed light-emitting 
diode array with peak output at 625 nm (OTL630A-5-10-
66-E, Opto Technology, Inc., Wheeling, IL, USA). Emit-
ted phosphorescent light was detected by a Hamamatsu 
photomultiplier tube (928) after first passing it through 
a wide-band interference filter centered at 800  nm. 
The amplified phosphorescence decay was digitized at 
1.0 MHz by a 20-MHz A/D converter (Computer Boards, 
Inc., Mansfield, MA, USA).
A program was developed using Microsoft Visual Basic 
6, Microsoft Access Database 2007, and Universal Library 
components (Universal Library for Measurements Com-
puting Devices; http://www.mccdaq.com/daq-software/
universal-library.aspx). It allowed direct reading from 
the PCI-DAS 4020/12 I/O Board (PCI-DAS 4020/12 I/O 
Board; http://www.mccdaq.com/pci-data-acquisition/
PCI-DAS4020-12.aspx). The pulse detection was accom-
plished by searching for 10 phosphorescence intensities 
>1.0 V (by default). Peak detection was accomplished by 
searching for the highest 10 data points of a pulse and 
choosing the data point closest to the pulse decay curve 
[34].
The phosphorescence decay rate (1/τ) was character-
ized by a single exponential; I  =  Ae−t/τ, where I  =  Pd 
phosphor phosphorescence intensity. The values of 1/τ 
were linear with dissolved O2 : 1/τ = 1/τ ◦ + kq[O2], 
where 1/τ = the phosphorescence decay rate in the pres-
ence of O2, 1/τ° = the phosphorescence decay rate in the 
absence of O2, and kq = the second-order O2 quenching 
rate constant in s−1 μM−1 [35].
Spinal cord tissue respiration was measured at 37°C 
in 1 ml sealed vials. Mixing was carried out with the aid 
of parylene-coated stirring bars. In vials sealed from air, 
[O2] decreased linearly with time, indicating the kinetics 
of mitochondrial O2 consumption was zero-order. The 
rate of respiration (k, in μM O2 min−1) was thus negative 
of the slope d[O2]/dt. Sodium cyanide (NaCN) inhibited 
respiration, confirming that O2 was being consumed in 
the mitochondrial respiratory chain.
Calibration with β-glucose plus glucose oxidase: The 
calibration reaction contained PBS with 3 μM Pd phos-
phor, 0.5% fat-free albumin, 50 mg ml−1 glucose oxidase 
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and various concentrations of β-glucose. The values of 
1/t were linear with [β-glucose]; the value of kq was the 
negative of the slope (kq =  101.1  s−1 μM−1). The value 
of 1/τ for air-saturated solution (without glucose) was 
28,330  s−1 (coefficient of variation, Cv  =  12%) and for 
O2-depleted solution (with 500  mM β-glucose, 1/τo) 
2,875 s−1 (Cv = 1%). The high values of Cv for the air-sat-
urated solutions were due to the lower phosphorescence 
intensities with high [O2] (little light reaching the photo-
multiplier tube). O2 concentration was calculated using, 
1/τ = 1/τ° + kq[O2] [35].
Dissolved O2 is expressed in mm Hg, ml O2  l−1, 
mg O2  l−1, or mmol  l−1 (mM). For conversion: a par-
tial pressure of oxygen (PO2) of 1.0  mm Hg  =  0.03  ml 
O2  l−1; 1.0  ml O2  l−1  =  1.4276  mg O2  l−1; 1.0  mg 
O2 l−1 = 1,000/32 μM. In freshwater at 760 mm Hg and 
20°C, dissolved [O2] is 9.1  mg  l−1, or 284  μM. Using a 
Clark electrode, the PO2 of our reaction mixture (PBS 
with 10  mM glucose, 3.0  μM Pd phosphor and 0.5% 
fat-free bovine serum albumin) was 170.5 [±6.6] mm 
Hg (n = 4), or 228 [±9] μM. The 56 mm Hg difference 
between [O2] in freshwater and the Pd solution reflects 
the effect of salinity on dissolved O2.
Intracellular caspase‑3 activity measurement by HPLC
Ac-DEVD-AMC is a synthetic substrate that enters cells 
rapidly and is cleaved by caspases to yield the fluorescent 
compound, 7-amino-4-methylcoumarin (AMC). Fol-
lowing cell disruption, any released AMC is separated 
by HPLC and detected by fluorescence. The use of the 
pan-caspase inhibitor zVAD-fmk results in a reduction 
in AMC peak area confirming that intracellular caspases 
are responsible for the cleavage reaction. Specimens 
(~40  mg) were incubated in oxygenated KH buffer con-
taining 74 μM Ac-DEVD-AMC with or without 43 μM 
zVAD-fmk (Calbiochem, La Jolla, CA, USA) for 30  min 
(final volume, 0.5 ml) at 37°C and processed as previously 
reported [16]. Briefly, the tissue was homogenized by 10 
passages through a 27-G needle and the Ac-DEVD-AMC 
(N-acetyl-asp-glu-val-asp-7-amino-4-methylcoumarin; 
m.w.  =  675.64; caspase-3 substrate, Axxora LLC San 
Diego, CA, USA) cleavage reaction was quenched with 
dilution, a procedure which renders caspases inactive. The 
supernatant was collected by centrifugation (16,300g for 
90  min) and separated on HPLC Waters 1525 reversed-
phase HPLC system (Spectra Lab Scientific Inc, Alex-
andria, VA, USA), and analyzed for the free fluorogenic 
AMC moiety [30]. The excitation wave length used was 
380 nm with an emission wave length of 460 nm. zVAD-
fmk solution (2.14 mM) was made by dissolving 1.0 mg in 
1.0 ml dimethyl sulfoxide and stored at −20°C. Ac-DEVD-
AMC solution (7.4 mM) was made by dissolving 5.0 mg in 
1.0 ml dimethyl sulfoxide and stored at −20°C.
ATP content measurement
Spinal cord fragments were homogenized in ice-cold 
2% trichloroacetic acid for 2  min and neutralized with 
100 mM Tris–acetate, 2 mM EDTA, pH 7.75. The super-
natant was collected by centrifugation (1,000×g at 4°C 
for 5 min) and stored at −20°C until analysis. The pH of 
samples was adjusted to 7.75 immediately before ATP 
determination. ATP concentration was measured using 
the Enliten ATP Assay System (Bioluminescence Detec-
tion Kit, Promega, Madison, WI, USA). Briefly, 2.5 μl of 
the acid-soluble supernatant was added to 25 μl of the 
luciferin/luciferase reagent. The luminescence intensity 
was measured at 25°C using Glomax Luminometer (Pro-
mega, Madison, WI, USA). The ATP standard curve was 
linear from 10 pM to 100 nM (R2 > 0.9999).
Histological analysis
Spinal cord specimens (n = 5) from immunized and non-
immunized animals were fixed in 4% phosphate-buffered 
paraformaldehyde by perfusion and routinely embedded 
in paraffin wax. Sections of thickness 5–7 µm were then 
stained with hematoxylin & eosin for light microscopy. 
The level of mononuclear cell infiltration was graded 
using the following semi-quantitative scoring: 0, no infil-
tration; 1, mild infiltration around pial vessels; 2, single-
cell infiltration within the CNS; 3, infiltration with mild 
perivascular cuffing; and 4, very intense infiltration with 
perivascular cuffing [12, 13].
Luxol fast blue microscopy
Procedures recommended by the manufacturers were 
applied. Briefly, 5–7  μm thick sections of paraffin wax 
embedded spinal cords from immunized DA (grade 3 
disease) and AO rats were deparaffinized in two changes 
of xylene for 10 min, hydrated in changes of series of 100 
and 95% alcohol. The sections were incubated in Luxol 
Fast Blue (LFB) solution in 56°C oven overnight. After 
rinsing off excess LFB with 95% alcohol and distilled 
water, sections were differentiated in lithium carbonate 
solution and 70% alcohol for 30 s each, followed by a final 
rinse in distilled water. After checking for completion 
of differentiation under the microscope, sections were 
counterstained in cresyl violet solution for 1–2 min, cov-
ers lipped with DPX and examined under the Zeiss axi-
ophot microscope to which a digital camera is attached.
Immunohistochemistry
To determine the presence and source of caspase-1, 
5–7 μm thick sections of paraffin wax embedded spinal 
cords from immunized DA (grade 3+ disease) and AO 
rats were stained by double immunofluorescence poly-
clonal rabbit anti-caspase-1 (Abcam, Cambridge, USA) 
and Iba-1 and caspase-1 and GFAP and Goat polyclonal 
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anti-ionized calcium-binding protein (Iba-1; Wako, Ger-
many) which unlike other microglial markers is expressed 
by all subpopulations of microglia [25] and anti-mouse 
glial fibrillary acidic protein (GFAP; Vector Laboratories 
Inc., CA, USA) for astrocytes [26]. Briefly, rehydrated 
sections were transferred into 0.1  M citrate buffer and 
boiled in a 750  W microwave for antigen retrieval. The 
sections were incubated with the antibodies diluted 1:200 
in BSA/0.1  M PBS overnight at 4°C. Control sections 
were treated with antibodies preadsorbed with peptides 
provided from the same sources as antibodies at a con-
centration of 10−6  M. On the following morning, sec-
tions were washed 3× for 5 min, incubated with the link 
antibody comprising fluorescein isothiocyanate (FITC) 
bound anti-rabbit IgG and rhodamine (RRX) bound anti-
goat or mouse IgG (Jackson ImmunoResearch Laborato-
ries Inc., USA) diluted 1:100 in BSA/0.1  M PBS for 1  h 
at room temperature. Sections were coverslipped with 
immunomount (Shandon, Pittsburgh, USA) and exam-
ined by a Nikon Eclipse 80i confocal microscopy with 
Nikon D Eclipse C1 single photon laser probe.
Quantification of caspase‑3 immunoreactive cells
Non-contiguous sections of the spinal cord taken from 
the lumbar region (L3) were used for quantification. 
The total number of caspase-3 immunoreactive cells 
per section present in three non-contiguous sections 
(every 5th section) of the spinal cord of immunized 
DA (grade 3 diseased; n = 5) and AO rats was obtained 
by counting using a ×20 objective on a Zeiss axiophot 
photomicroscope.
Electron microscopy
Sections of the spinal cord from immunized DA (n = 4, 
grade 3–4 disease), non-immunized DA (n  =  4) and 
immunized but resistant AO rats (n =  4) were fixed by 
perfusion with freshly prepared Karnovsky’s solution. 
Sections from the lumbar region were then further fixed 
by immersion in Karnovsky’s solution for 18 h and rou-
tinely processed for electron microscopy. Thick sections 
(1–2 μm) from corresponding areas of the spinal cords 
of the different groups of rats were stained with toluidine 
blue and examined under the light microscope to con-
firm the areas for electron microscopy. Ultrathin sections 
of 60–90  nm thickness were then cut with a Delaware 
diamond knife (Agar Scientific Ltd., Cambridge, UK) 
and mounted on 3 mm 200 carbon grids. The grids were 
contrast-stained with saturated aqueous uranyl acetate 
and lead citrate and examined with the Phillips CM10 
transmission electron microscope. Thin sections were 
taken from areas of the spinal cord showing mononuclear 
cellular infiltration in diseased DA rats. For comparison 
similar areas of the spinal cords of immunized AO and 
non-immunized DA rats were also examined by electron 
microscopy.
Quantification of mitochondrial and axonal sizes
A total of three non-contiguous grids from four immu-
nized diseased DA, non-immunized DA and AO rat 
spinal cords (2 per rat) were analyzed. Sections were 
examined at ×27,000 magnification and the perimeter of 
each mitochondrion and that of the axon within which it 
occurred measured using the Image J analysis software. 
The ratio of mitochondrial size to that of the axon was 
then determined for each group of immunized DA and 
AO rats. Measurements were taken only if the whole pro-
file of the axon could be seen.
Statistical analysis
Data were analyzed using SPSS statistical package (ver-
sion 19). The nonparametric test (2 independent vari-
ables) Mann–Whitney was used to compare readings of 
immunized and non-immunized samples.
Results
As previously reported [13, 14], AO and DA rats react 
differently to disease induction as evaluated by clini-
cal criteria in that while DA rats are susceptible, AO 
rats are resistant to disease induction. DA and AO rats 
were immunized in the foot pads with MBP in complete 
Freund’s adjuvant. Disease development in DA rats nor-
mally became evident by day 10 and reached the peak 
around day 14. AO rats never developed the disease (Fig-
ure  1a). The difference in disease scores was confirmed 
by histopathological analysis of the spinal cord, with the 
DA rats showing significantly severe inflammation and 
the presence of perivascular cuffing at the peak of dis-
ease (Figure  1b–d). There was a significant difference 
in the incidence of the disease (Figure  1g) and this was 
confirmed by quantitative measurement of the histologi-
cal scores (Figure 1h). As shown in Figure 1e, f, evidence 
of demyelination as demonstrated LFB staining [36, 37] 
was minimal and detectable only around areas of mono-
nuclear cellular infiltration of the cord in DA rats at the 
peak of clinical disease.
Cellular respiration and ATP content
O2 consumption by spinal cord tissue was measured 
using excised specimens from immunized and non-
immunized DA rats at different stages of the disease. 
In addition, O2 consumption was compared between 
immunized DA and AO rats. Respiration was inhibited 
by cyanide, confirming that oxidation had occurred in 
the mitochondrial respiratory chain. We demonstrate 
here that the differences in the rate of respiration (kc, 
in μM O2 min−1 mg−1) between non-immunized and 
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immunized DA rats at the inductive phase of grades 
1–2 (p = 0.897) and peak phase of grades >3 (p = 0.933) 
were not significant. The differences in the values of 
kc between non-immunized and immunized AO rats, 
which did not develop disease, were also not significant 
(p = 0.722) (Figure 2a–c). Thus clearly spinal cord respi-
ration was not diminished during the course of disease. 
Consistently, cellular ATP (expressed in pmol mg−1) was 
also preserved throughout the course of disease in immu-
nized DA rats (Figure 1d) with no significant differences 
between that of immunized diseased DA and immunized 
AO rats at the different clinical stages of the disease (Fig-
ure 2d). There were no significant differences in cellular 
ATP content between immunized and non-immunized 
DA rats (data not shown).
Caspase‑3 and caspase‑1 activities are both elevated 
in diseased DA rats
Caspases are a family of endoproteases that provide 
critical links in cell regulatory networks controlling 
Figure 1 DA rats develop EAE while AO rats are resistant. DA (b–d) developed severe EAE whilst AO rats did not (a). Rats were immunized with 
MBP in complete Freund adjuvant. a, c Low magnification micrographs of sections of the spinal cord of AO and DA rats respectively; b, d high 
magnification micrographs of spinal cord sections of DA rats examined 14 days after immunization using H&E staining. Note the presence of typical 
perivascular and subpial infiltrates of different sizes in areas of the spinal cords of DA rats (b, d). g Clinical scores show that DA rats become severely 
diseased with time, whereas AO rats do not develop the disease. Results are mean clinical scores ± SEM (n = 5, representative of four experiments, 
p < 0.001). h A cumulative graph of semiquantitative assessment of the histological score of disease from the spinal cords of DA and AO rats of 10 
noncontiguous sections per spinal cord (p < 0.001, n = 3). e Micrographs of Luxol fast blue‑stained sections of the spinal cord of immunized DA rats 
at peak of disease (n = 5). The dorsal column (square box) of the DA rat is enlarged in f to show areas of infiltration around which there seem to be 
evidence of demyelination (arrows). Bar 20 μm.
Page 7 of 13Al‑Shamsi et al. BMC Neurosci  (2015) 16:37 
inflammation and cell death [20]. By means of caspase-3 
and caspase-1 immunoreactivity, we have studied the 
roles of apoptosis and inflammation in encephalitogen-
induced EAE. We first determined whether there was 
any difference in caspase-3 activity in spinal cord tissue 
of immunized diseased DA and immunized resistant 
AO rats at the peak of disease by immunohistochem-
istry and demonstrate here in Figure  3a–c, that there 
were significantly more caspase-3 immunoreactive cells 
in spinal cords of diseased DA rats compared to that 
in resistant AO rats (244 ± 6 vs 8 ± 2, p < 0.0004). We 
then proceeded to monitor caspase-3 activity during the 
pathology of EAE using immunized DA rats at differ-
ent stages of disease. This was compared with activity in 
non-immunized DA rats using an assay which detects 
by fluorescence, the presence of 7-amino-4-methylcou-
marin (AMC). This fluorogenic moiety was separated by 
HPLC from supernatants of homogenized spinal cord 
tissue (retention time, Rt, ~5.2 min). Representative runs 
of caspase activity at the peak of disease (grade 3–3.5) 
of immunized as well as of non-immunized animals 
are shown in Figure  4a–c respectively. When the AMC 
Figure 2 Spinal cord tissue respiration in immunized and non‑immunized rats. a A summary of all kc values (involving 33 rats) as a function disease 
grade for (i), immunized DA with grade 1–2 disease (ii), immunized DA rats with grade 3+ disease (iii) and immunized but resistant AO rats (iv). b 
Representative experiment of cellular respiration in immunized and non‑immunized DA rats with different grades of disease showing the values of 
kc as a function of days after immunization. c Representative runs of O2 consumption by spinal cord tissue from non‑immunized (i), immunized with 
grade 1‑2 disease (ii) and immunized with grade 3+ disease (iii) DA rats. Addition of 10 mM NaCN and 50 μg ml−1 glucose oxidase are shown. Rates 
of respiration (kc, in μM O2 min
−1 mg−1) are shown at the bottom of the runs. d Cellular ATP content in immunized DA and AO rats on days 6, 10 
and 24 after immunization. The error bars are standard deviations (n = 3 independent samples).
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Figure 3 Spinal cord caspase activity in immunized and non‑immunized DA rats. A representative micrograph of sections of the spinal cord 
from diseased DA rats (a grade 3.5; n = 4) and immunized but resistant AO (b) rats (n = 4) immunostained with polyclonal rabbit anti‑caspase‑3. 
Caspase‑3 positive cells (arrows) were observed only in DA rats. c A graph of the number of caspase‑3 immunoreactive cells in sections of spinal 
cords. Spinal cord specimens were also incubated in oxygenated KH buffer plus Ac‑DEVD‑AMC with and without zVAD‑fmk. The tissues were then 
disrupted by homogenization and the supernatants were separated on HPLC and analyzed for AMC peak. di depicts representative runs of dH2O 
and substrate injections, dii runs of spinal cord tissue caspase activity of non‑immunized DA rat and diii representative runs of spinal cord tissue 
caspase activity of immunized DA rat at the peak of clinical disease. div AMC peak areas were plotted as a function of days after immunization in DA 
rats. A peak, indicative of caspase activity is significant only in DA rats at the peak of clinical disease. This is further confirmed in graphs of AMC peak 
areas as a function of days after immunization (complete lines). Note how caspase activity rises from induction (1), grade 2 disease (2), till peak of 
clinical disease (3) and recovers (4) to levels similar to that of (1) after recovery. This is not observed in resistant AO rats (dotted lines). Bar 25 μm.
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Figure 4 Caspase‑1 immunoreactivity is present in infiltrating mononuclear cells and microglia. Panels show representative cryostat sections of 
spinal cord from the lumbar region of AO (a–c, g–i) and DA rats at the peak of disease (d–f, j–l) 15 days after immunization (n = 4). Micrographs a, 
d, g and j, have been stained by indirect double immunofluorescence with polyclonal rabbit anti caspase‑1 (FITC‑green), b, e with goat anti‑Iba‑1, 
and h, k with monoclonal mouse anti‑GFAP (both RRX‑red) and examined by confocal microscopy. Note the intense immunoreactivity to caspase‑1 
(d infiltrating mononuclear cells) and Iba‑1 (e activated microglia) and their co‑localization in diseased DA rats (f). Note also that caspase 1 is absent 
in GFAP‑immunoreactive astrocytes (l). Bar 10 μm.
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peak areas [corrected for background peaks of dH2O 
(area  =  451,431  ±  arbitrary units) and substrate injec-
tions (area  =  844,792  ±  arbitrary units)] as a function 
of days after immunization were plotted, the free AMC 
moiety was noted only at the peak of disease, with a peak 
area of 1,336,600  ±  arbitrary units (Figure  3di–iv). In 
all runs, zVAD-fmk blocked AMC peak, confirming the 
Ac-DEVD-AMC cleavage reaction was mediated by cas-
pases. Thus, the treatment with encephalitogen resulted 
in increased caspase activity only at the peak of disease. 
These results are consistent with the above noted pre-
served spinal tissue respiration and ATP content during 
the entire course of EAE. 
We also investigated whether the differences in the 
pathology of EAE in the two species was also evident in 
the level of neuroinflammation as demonstrated by the 
expression of caspase-1 immunoreactivity in the spinal 
cords of immunized DA and AO rats. We demonstrate 
here that caspase 1 immunoreactivity was significantly 
upregulated in DA rats. We also show here by double 
immunofluorescence that caspase-1 is co-localized with 
both mononuclear cells and activated microglia found 
in diseased DA rats (Figure  4f ) but not with ramified 
resting microglia (Figure 4f ) in AO rats nor in astrocytes 
in both diseased DA and resistant AO rats (Figure 4i, l). 
As expected, activation of microglia and immunoreactiv-
ity with caspase-1 both disappear in DA rats when EAE 
resolves (figure not shown).
Electron microscopy
We further examined areas of the white mater of the 
spinal cords of AO and DA rats by electron microscopy 
to confirm the demyelination observed by LFB staining 
and to determine whether this was associated with any 
damage of mitochondria within both demyelinated and 
undamaged axons. The effect of EAE on mitochondrial 
size was assumed to be a measure of the functional status. 
As shown in (Figure  5a–d), myelin fibers around nerve 
fibres in the spinal cords of DA rats showed significant 
evidence of demyelination including splitting of the mye-
lin sheath either at the major dense line or at the intra-
period line and stripping of nerve fibres. Myelin around 
some nerves were partially lost or seemed to be in the 
process of being lost. These observations were absent in 
non-immunized normal DA and immunized but resistant 
AO rats. Unexpectedly, although they appeared normal 
Figure 5 Ultrastructural features of nerve fibres of rats at the peak of clinical disease of EAE. Electron micrographs of sections of the spinal cord 
of non‑immunized DA (a), immunized AO (b), and grade 3 diseased DA (c, d) rats (n = 4; 3 non‑contiguous grids). Note the normal myelination of 
fibres in spinal cords of both non‑immunized DA and immunized AO rats. Note also the evidence of demyelination in c and d (thin arrows) includ‑
ing splitting of the myelin sheath either at the major dense line or at the intraperiod line. Also present are areas where there seem to be stripping 
of the nerve fibres of myelin (thick arrows). e A graph comparing the size of mitochondria in AO with that in DA spinal cords. Note that as shown 
in e, despite the normal appearance of mitochondria in axons of diseased DA rats (DAi), they are significantly smaller (p < 0.005) compared with 
those in the axons of immunized AO (AO) and non‑immunized DA (DAni) rats. Note also that there is no significant difference in the ratio of the 
mitochondrial:axonal sizes in the immunized diseased DA and resistant AO rats (p = 0.08; f). Bar a, b 0.1 μm; c, d 0.5 μm.
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in structure, mitochondria from spinal cords of diseased 
DA rats (4.8 ± 0.7 × 109 mm2) were significantly smaller 
compared with those from non-immunized and normal 
DA (6.95 ±  0.8 ×  109 mm2) and immunized but resist-
ant AO rats (7.03 ± 1 × 109 mm2; p < 0.001; Figure 5e). 
It is noteworthy that in spite of the differences in sizes of 
mitochondria, the difference in the ratio of mitochondrial 
size:axonal size in diseased DA rats and the immunized 
AO rats was not significant (3.28 × 10−6 ± 0.29 × 10−6 vs 
3.82 × 10−6 ± 0.24 × 10−6; p = 0.072; Figure 5f ).
Discussion
Experimental autoimmune encephalomyelitis, a rodent 
model for relapsing/remitting type of multiple sclero-
sis in humans, is a T cell mediated disease of the CNS 
characterized by local inflammatory infiltrates of myelin 
antigen-specific T cells and demyelination. DA rats are 
highly susceptible to EAE, whereas AO rats are resist-
ant to disease induction [13, 14] even after immunization 
with CFA and spinal cord homogenate [4], although mild 
inflammatory infiltrates are observed in both strains early 
after disease induction [23]. The cellular and inflamma-
tory infiltrates responsible for the different stages of EAE 
have been identified to include myelin antigen-specific T 
cells, B cells, as well as macrophages/monocytes, neutro-
phils and dendritic cells [24, 36, 38]. The natural history 
of the disease has therefore been extensively studied, but 
how these cells influence spinal cord tissue bioenergetics 
is yet to be elucidated.
In this study, we have applied a highly sensitive analyti-
cal method that measures cellular bioenergetics (cellular 
mitochondrial O2 consumption and intracellular caspase 
activity) to describe the cellular bioenergetics during 
the course of EAE and to correlate the results with the 
pathology of the disease. The data show for the first time 
that spinal tissue respiration and ATP content are pre-
served throughout the first wave of EAE.
Ac-DEVD-AMC is a synthetic substrate that enters 
cells rapidly and is cleaved by caspases to yield the fluo-
rescent compound, AMC. Following cell disruption, any 
released AMC is separated via HPLC and detected by 
fluorescence. The reduction in AMC peak area due to the 
pancaspase inhibitor zVAD-fmk confirms that intracellu-
lar caspases are responsible for the cleavage reaction. As 
shown in Figure 3, the AMC peak was first noted at the 
peak of clinical disease (grade 3.5) and was significantly 
reduced by zVAD-fmk. These observations correlated 
with the morphological evidence that anti-caspase-3 
immunoreactivity was most significantly increased at the 
peak of clinical disease. Therefore, the data clearly shows 
and confirms that the enhanced caspase-3 activity plays a 
significant role in the development of clinical disease [3].
Multiple sclerosis and experimental autoimmune 
encephalomyelitis have both been attributed to the loss 
of oligodendrocytes by apoptosis [39, 40] and hence the 
probable source of caspase-3 but why and how the dis-
ease resolves in rodents remains to be elucidated. Fur-
ther studies are needed to precisely elucidate the cellular 
bioenergetic profile of spinal cord tissue at the induc-
tion, peak and resolution phases of EAE. Such a task 
would require separating and studying the different cell 
populations at these phases of EAE. Nevertheless, the 
important contribution here is that despite prominent 
intracellular caspase-3 activity at the peak of disease in 
DA rats, regardless of its source, the cellular bioenerget-
ics remains preserved. The preserved spinal cord tissue 
metabolic energy in EAE is consistent with the usual 
clinical recovery observed in animals. Further, we have 
demonstrated the heightened inflammation at the peak 
of disease as evidenced by the increased production of 
caspase-1 by mononuclear cells and activated micro-
glia [27, 28, 41–45] at the peak of disease. Therefore this 
increased caspase activity and inflammation seem to 
occur probably with very little effect on mitochondrial 
function.
While demyelination is recognized as the classical tar-
get in EAE and MS, axonal and neuronal loss are now 
also considered as important causes of persistent clini-
cal disability and the role of mitochondria for both pro-
cesses is considered substantial [1, 2, 7, 8, 38, 46–49]. 
We observed that mitochondria in regions of mononu-
clear cellular infiltration of the cord were smaller in size. 
Bando et al. [50] have recently reported the disruption in 
the mitochondrial fusion/fission machinery in axons in 
EAE and shown that DLP1/Drp1, a mitochondrial fission 
related protein, was up-regulated while MFN1, a mito-
chondrial fusion-related protein, was down-regulated in 
EAE. Changes in mitochondrial morphology in neurons 
and astrocytes have also been attributed to changes in 
calcium dependent and independent cycling pathways 
[51, 52]. Mitochondrial morphology is however, dynamic 
and further studies that would examine changes in mito-
chondrial morphology at the different stages of EAE 
would be essential [53]. It is more important to note how-
ever, that the difference in the ratios of mitochondrial 
size to axonal diameter in diseased DA and resistant AO 
rats was not significant.
It appears in this study that demyelination at this ini-
tial stage of the disease is localized only to areas of infil-
tration and the present technique might not therefore, 
be sensitive enough to detect the effect of these limited 
changes on respiration in the whole of the central nerv-
ous system. Further studies using a model of chronic EAE 
would be required to address this concern.
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The evidence from this study on the role of mitochon-
drial in demyelination and in EAE is therefore minimal, 
but it should be plausible to speculate that recovery of 
rats in this model, as has been observed in this and other 
studies [30] and in mice [1] could be due to the presence 
of the large population of normally functioning mito-
chondria in areas of the spinal cord which showed no evi-
dence of disease.
Conclusion
In summary, we hypothesized that the preserved cellular 
bioenergetics in our study might underlie the remission 
from disease in this model but in the light of our findings 
it would be more appropriate to test this hypothesis using 
proteolipid protein (PLP)-induced EAE in SJL/J mice. 
This would enable the investigation of any alterations in 
bioenergetics accompanying relapse and the transition to 
chronic EAE [54].
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